The Third Annual STG ’10 Invitational Golf Outing being held in loving memory of Sarah Tarditi Gallagher to benefit the Leukemia Lymphoma Foundation will take place on Monday, July 26 at Tavistock Country Club in Haddonfield.
Every five minutes, someone is newly diagnosed with blood cancer. Leukemia remains the leading cause of cancer-related deaths in children. Almost 900,000 Americans are living with leukemia, lymphoma or myeloma. There is no known cure for them.
“Finding out our daughter, Sarah, had cancer truly made our world stop. Knowing she was pregnant made it worse. Seeing her suffer was crushing. Losing her to leukemia was devastating,” the Tarditis said. “Aimee’s children, who were very close with their ‘Tante,’ always talk of growing up and finding a cure for cancer so no one needs to be sad like they were. So no one needs to be motherless. You can be part of this cure.”
Golfers can participate in the Third Annual STG’10 Invitational in foursomes or as individuals. Companies and individuals can also help by sponsoring holes, golf carts, refreshments or dinner for the event. Non-playing individuals can attend the dinner, which begins with cocktails at 5 p.m. Personal donations are welcomed and appreciated.
Contributions made on behalf of Sarah Tarditi Gallagher to the STG Fund are invested in the cure for all cancers — since most life-saving cancer treatment methods were first pioneered in the treatment of leukemia. These treatments include chemotherapy, radiation, bone marrow transplantation and new targeted drug therapies that kill cancer cells without haring normal ones. Hopefully, cures will be found that do not require such devastating treatments as radiation and chemotherapy.
The Leukemia and Lymphoma Society depends entirely on contributions from individuals, special events, corporations and foundations like STG. LLS has invested more than $600 million in research. This money has led to key advances in understanding blood cancers and life saving drugs and treatments to fight them. Since 1960, the five-year survival rate for leukemia has quadrupled to 51.2 percent and the survival rate for Hodgkin lymphoma has doubled to more than 86 percent.
For further information or to register, call Dean Smith at 988–6777 or feel free contact a member of the committee.
